Scarica l'app Stockscreener
5.01
1.83%
0.09
Dopo l'orario di chiusura:
5.00
-0.010
-0.20%
Aardvark Therapeutics Inc Borsa (AARD) Ultime notizie
INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Aardvark Therapeutics, Inc. (AARD) to Contact Law Firm - PR Newswire
Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Aardvark Therapeutics Faces Investor Class Action - stl.news
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline - PR Newswire
AARDVARK THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and DirectorsAARD - PR Newswire
AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action LawsuitInvestors With Losses May Contact SueWallSt - PR Newswire
Attention Long-Term Shareholders of Aardvark Therapeutics, - GlobeNewswire
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 Deadline - PR Newswire
DEADLINE ALERT for HDB, SMPL, and AARD: The Law Offices of - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in Aardvark Therapeutics, Inc. LawsuitAARD - PR Newswire
AARD Stock Plummets After Hours As Cardiac Safety Concerns Trigger FDA Hold On Late-stage Program - Stocktwits
Aardvark Therapeutics Becomes Next Pharma Player To Quit Prader-Willi Syndrome Drug Development Efforts - Stocktwits
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AARD - GlobeNewswire Inc.
Aardvark Therapeutics Lawsuit: Investors Can Lead Securities Fraud Case - WBOC TV
AARDVARK THERAPEUTICS, INC. (AARD) SHAREHOLDER ALERT - GlobeNewswire
Deadline Alert: Aardvark Therapeutics, Inc. (AARD) - GlobeNewswire
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit - The Conway Daily Sun
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
2026-09-06 | AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AARD | Press Release - Stockhouse
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Rosen Law Firm Urges Aardvark Therapeutics, Inc. (NASDAQ: AARD) S - The National Law Review
Faruqi & Faruqi, LLP Urges Aardvark Therapeutics (NASDAQ: AARD) Investors to Seek Counsel Before October 13, 2026 Lead Plaintiff Deadline in the Securities Class Action - PR Newswire
AARD Shareholder Alert: October 13, 2026 Lead Plaintiff Deadline in Aardvark Therapeutics, Inc. Securities Class ActionContact SueWallSt - PR Newswire
AARD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AARD Investor Alert: Aardvark Therapeutics, Inc. Securities Class Action NoticeContact Levi & Korsinsky - Morningstar
Shareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Aardvark Therapeutics, Inc. Class Action Lawsuit Alert: - GlobeNewswire
Important Notice to Long-Term Shareholders of Aardvark - GlobeNewswire
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AARD UPCOMING DEADLINE: Levi & Korsinsky Alerts Aardvark - GlobeNewswire
Important Notice to Long-Term Shareholders Aardvark - GlobeNewswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Aardvark - GlobeNewswire
AARD STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Faruqi & Faruqi, LLP Urges Aardvark Therapeutics (AARD) Investors - The National Law Review
AARD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Robbins LLP Urges AARD Stockholders Who Lost Money Investing in Aardvark Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action - PR Newswire
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (AARD) to Filing of Securities Class Action - TMX Newsfile
Bragar Eagel & Squire, P.C. Announces that a Class Action - GlobeNewswire
AARD DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Aardvark Therapeutics, Inc. Investors to Join the Class Action Lawsuit Today - ACCESS Newswire
Deadline Approaching: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith - The Chronicle-Journal
AARD DEADLINE: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire
Portnoy Law Firm Announces Class Action on Behalf of Aardvark Therapeutics, Inc. Investors - GlobeNewswire
Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit - Business Wire
ROSEN, A TOP RANKED LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionAARD - ACCESS Newswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aardvark - GlobeNewswire
Did You Lose Money Investing in Aardvark Therapeutics, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against AARD - newsfilecorp.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Shareholders who lost money in shares of acquired Aardvark - GlobeNewswire
Aardvark Therapeutics, Inc. (AARD) LawsuitInvestors Urged to Contact Levi & Korsinsky Before October 13, 2026 - ACCESS Newswire
2026-08-21 | Faruqi & Faruqi, LLP Urges Aardvark Therapeutics (NASDAQ: AARD) Investors to Seek Counsel Before October 13, 2026 Lead Plaintiff Deadline in the Securities Class Action | NDAQ:AARD | Press Release - Stockhouse
Aardvark Therapeutics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsAARD - WBOC TV
Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Sahm
ROSEN, RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages - GlobeNewswire
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):